临床试验

Drug Screening Using IMD in Bladder Cancer

NCT：NCT06204614 · ENROLLING_BY_INVITATION

NCT编号NCT06204614

状态ENROLLING_BY_INVITATION

开始日期2024-06-14

完成时间2028-08-01

SponsorBrigham and Women's Hospital (OTHER)

First posted2024-01-12

Last updated2026-05-18

简要摘要

This research study involves implanting up to 4 microdevices, each small enough to fit inside the tip of a needle, into a tumor. These devices will release microdoses (many thousands of times less than a treatment dose) of different cancer drugs into the tumor. After approximately 72 hours, the devices and small regions of surrounding tissue will be removed and studied. There will be a follow-up visit within 42 days of device removal to assess for potential safety issues or side effects.

官方来源

在 ClinicalTrials.gov 上查看 →

数据来自 ClinicalTrials.gov API。有关最新状态，请参阅官方记录。